BioInnovatise Launches New sgRNA Cloning Service for Biotechnology and Biopharmaceutical Research and Development

BioInnovatise Launches New sgRNA Cloning Service for Biotechnology and Biopharmaceutical Research and Development

April 3, 2025

Rockville, MD — BioInnovatise is proud to announce the launch of its cutting-edge sgRNA Cloning Service, designed to enhance CRISPR-based research and genome editing applications. This service reinforces BioInnovatise’s commitment to providing high-precision molecular cloning solutions that support researchers in gene editing, functional genomics, and therapeutic development.

Unlock precise genome editing with our comprehensive CRISPR-Cas9 services. Our specialized sgRNA Cloning service ensures optimal targeting efficiency for gene editing projects, creating guide RNAs with exceptional specificity and functionality. This service seamlessly integrates with our CRISPR vector production, CRISPR cassette production and donor vector construction design, and CRISPR knock-in and knock-out services, offering a complete genome editing toolkit.

Quick Turnaround sgRNA Cloning for Research and Development

Our new sgRNA Cloning Service enhances our portfolio of molecular biology services, providing researchers with flexible and highly customizable solutions for CRISPR-based applications. Whether you require single-guide RNAs (sgRNAs) for knock-out, activation, or inhibition studies, our platform delivers high-fidelity constructs with optimized expression and efficiency.

Step-by-Step sgRNA Cloning Process

Step 1: Determine Target Gene Details

Step 2: Decide CRISPR Experimental Design

Step 3: Choose sgRNA Design Specifications

Optional Step 4: Provide Experimental Context

About BioInnovatise

BioInnovatise is a leading CDMO specializing in high-quality support for plasmid DNA and viral vector research. Our services are designed to deliver efficient and reliable solutions for advancements in cell and gene therapy, immunotherapy, precision medicine, and more.